Acute Leukemia Perspective

• ASH 2023 Read clinically focused news coverage of key developments from ASH 2023
  Medscape Oncology, December 04, 2023
• Episode 6: Fertility, Pregnancy and Chronic Myeloid Leukemia   Drs Michael J. Mauro and Jane F. Apperley answer key questions about pregnancy and family planning for patients diagnosed with chronic myeloid leukemia, including complications and treatment options.
  Medscape, October 24, 2023
• Episode 5: Monitoring and Diagnostics in Chronic Myeloid Leukemia   Drs Michael J. Mauro and Jerald P. Radich discuss monitoring and diagnostics in chronic myeloid leukemia, including the Philadelphia chromosome and how it plays into the current treatment of CML.
  Medscape, September 28, 2023
• Episode 6: The Future of CAR T-cell Therapy   Join Drs Amelia Langston and Frederick Locke as they discuss the future of CAR T-cell therapy research and treatment.
  Medscape, September 12, 2023
• SOHO 2023 Read clinically focused news coverage of key developments from SOHO 2023
  Medscape Oncology, September 08, 2023
• Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  Medscape, September 07, 2023
• Episode 3: Developments and Challenges in Chronic Myeloid Leukemia   Drs Michael J. Mauro and Jorge E. Cortes discuss developments in the therapeutic landscape of chronic myeloid leukemia, complexities of resistance, and the potential for treatment-free remission.
  Medscape, July 27, 2023
• Highlights on Thrombosis and Hemostasis From EHA 2023   Thrombosis and hemostasis highlights from EHA 2023 identify VTE as a major complication in acute promyelocytic leukemia, biomarkers for VTE in lung cancer, and an investigational thrombosis inhibitor.
  Medscape, June 29, 2023
• EHA 2023 Read clinically focused news coverage of key developments from EHA 2023
  Medscape Oncology, June 19, 2023
• Episode 3: CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia   Join Drs Amelia Langston and Bijal Shah as they discuss CAR T-cell therapy for B-cell acute lymphoblastic leukemia, including clinical trials and real-world experience from their centers.
  Medscape, June 13, 2023
• How the Stars Align to Cure HIV   The apparent cure of a woman's HIV infection shines a light on the potential of cord blood compared with bone marrow transplantation.
  Medscape, March 16, 2023
• 75 Years: A Look Back on Methotrexate's Fascinating History Dr David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate's importance for immune-mediated inflammatory diseases.
  Medscape Rheumatology, January 25, 2023
• More Guidance Needed for Cancer Screening in Rheumatology Karmela Kim Chan, MD, discusses new myositis cancer screening guidelines as a good starting point for future needed efforts to guide cancer screening in patients with rheumatic diseases.
  Hospital for Special Surgery, January 12, 2023
• Advances in CAR-T Cell Therapy From ASH 2022   Novel CD7 and CD22 targets and improved outcomes with idecabtagene vicleucel and lisocabtagene maraleucel are among the advances in CAR T-cell therapy from ASH 2022, as selected by Dr Michael Bishop.
  Medscape, December 30, 2022
• SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib   Maurie Markman, MD, discusses 7-year follow-up results of the SOLO1 study in patients with advanced ovarian cancer and a BRCA mutation.
  Medscape Oncology, December 12, 2022
• ASH 2022 Read clinically focused news coverage of key developments from ASH 2022
  Medscape Oncology, December 02, 2022
• Bias and Other Barriers to HSCT Access Bias, defined as a prejudice in favor of or against a specific treatment on the part of physicians and patients, has not been carefully studied in the realm of cellular therapies.
  MDedge, September 02, 2022
• Episode 6: MRD and Relapse in Patients With AML   Drs Gail Roboz and Roland Walter discuss measurable residual disease and relapse in patients with acute myeloid leukemia.
  Medscape, August 17, 2022
• Episode 5: Treating Older AML Patients and Managing Unique Toxicities   Drs Gail Roboz and Courtney DiNardo discuss methods of treating older patients with acute myeloid leukemia and managing unique toxicities.
  Medscape, July 20, 2022
• New Options in Myelodysplastic Syndromes From ASCO 2022   Novel treatment options in lower- and higher-risk patients with myelodysplastic syndromes and a promising targeted therapy are among MDS highlights from ASCO 2022, as discussed by Dr Amy DeZern.
  Medscape, June 28, 2022